Selected research
Industry Research
Epigallocatechin Gallate (EGCG) Supplements Industry Research Report 2026
Market perspective
The global Epigallocatechin Gallate (EGCG) Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Epigallocatechin Gallate (EGCG) Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Epigallocatechin Gallate (EGCG) Supplements is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Epigallocatechin Gallate (EGCG) Supplements is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Epigallocatechin Gallate (EGCG) Supplements include Taiyo, Reliance Vitamin, Olimp Labs, NOW Sports, NESSO, Nature's Bounty, Herbalife, DSM and Botanic Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Epigallocatechin Gallate (EGCG) Supplements market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Epigallocatechin Gallate (EGCG) Supplements Market by Company
Taiyo
Reliance Vitamin
Olimp Labs
NOW Sports
NESSO
Nature's Bounty
Herbalife
DSM
Botanic Healthcare
Abbott Laboratories
Epigallocatechin Gallate (EGCG) Supplements Segment by Type
Pill
Tablet
Capsule
Others
Epigallocatechin Gallate (EGCG) Supplements Segment by Application
Pharmacy
E-commerce
Supermarket
Others
Epigallocatechin Gallate (EGCG) Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigallocatechin Gallate (EGCG) Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epigallocatechin Gallate (EGCG) Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigallocatechin Gallate (EGCG) Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Epigallocatechin Gallate (EGCG) Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Epigallocatechin Gallate (EGCG) Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Epigallocatechin Gallate (EGCG) Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pill
- Tablet
- Capsule
- Others
Applications
- Pharmacy
- E-commerce
- Supermarket
- Others
Companies covered
- Taiyo
- Reliance Vitamin
- Olimp Labs
- NOW Sports
- NESSO
- Nature's Bounty
- Herbalife
- DSM
- Botanic Healthcare
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Epigallocatechin Gallate (EGCG) Supplements Market Size (2021-2032)
- 2.2.2 Global Epigallocatechin Gallate (EGCG) Supplements Sales (2021-2032)
- 2.2.3 Global Epigallocatechin Gallate (EGCG) Supplements Market Average Price (2021-2032)
- 2.3 Epigallocatechin Gallate (EGCG) Supplements by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pill
- 2.3.3 Tablet
- 2.3.4 Capsule
- 2.3.5 Others
- 2.4 Epigallocatechin Gallate (EGCG) Supplements by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmacy
- 2.4.3 E-commerce
- 2.4.4 Supermarket
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Epigallocatechin Gallate (EGCG) Supplements Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Epigallocatechin Gallate (EGCG) Supplements Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Epigallocatechin Gallate (EGCG) Supplements Revenue of Manufacturers (2021-2026)
- 3.4 Global Epigallocatechin Gallate (EGCG) Supplements Average Price by Manufacturers (2021-2026)
- 3.5 Global Epigallocatechin Gallate (EGCG) Supplements Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Epigallocatechin Gallate (EGCG) Supplements, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Epigallocatechin Gallate (EGCG) Supplements, Product Type & Application
- 3.8 Global Manufacturers of Epigallocatechin Gallate (EGCG) Supplements, Established Date
- 3.9 Global Epigallocatechin Gallate (EGCG) Supplements Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Taiyo
- 4.1.1 Taiyo Company Information
- 4.1.2 Taiyo Business Overview
- 4.1.3 Taiyo Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Taiyo Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.1.5 Taiyo Recent Developments
- 4.2 Reliance Vitamin
- 4.2.1 Reliance Vitamin Company Information
- 4.2.2 Reliance Vitamin Business Overview
- 4.2.3 Reliance Vitamin Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Reliance Vitamin Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.2.5 Reliance Vitamin Recent Developments
- 4.3 Olimp Labs
- 4.3.1 Olimp Labs Company Information
- 4.3.2 Olimp Labs Business Overview
- 4.3.3 Olimp Labs Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Olimp Labs Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.3.5 Olimp Labs Recent Developments
- 4.4 NOW Sports
- 4.4.1 NOW Sports Company Information
- 4.4.2 NOW Sports Business Overview
- 4.4.3 NOW Sports Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 NOW Sports Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.4.5 NOW Sports Recent Developments
- 4.5 NESSO
- 4.5.1 NESSO Company Information
- 4.5.2 NESSO Business Overview
- 4.5.3 NESSO Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 NESSO Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.5.5 NESSO Recent Developments
- 4.6 Nature's Bounty
- 4.6.1 Nature's Bounty Company Information
- 4.6.2 Nature's Bounty Business Overview
- 4.6.3 Nature's Bounty Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nature's Bounty Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.6.5 Nature's Bounty Recent Developments
- 4.7 Herbalife
- 4.7.1 Herbalife Company Information
- 4.7.2 Herbalife Business Overview
- 4.7.3 Herbalife Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Herbalife Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.7.5 Herbalife Recent Developments
- 4.8 DSM
- 4.8.1 DSM Company Information
- 4.8.2 DSM Business Overview
- 4.8.3 DSM Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 DSM Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.8.5 DSM Recent Developments
- 4.9 Botanic Healthcare
- 4.9.1 Botanic Healthcare Company Information
- 4.9.2 Botanic Healthcare Business Overview
- 4.9.3 Botanic Healthcare Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Botanic Healthcare Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.9.5 Botanic Healthcare Recent Developments
- 4.10 Abbott Laboratories
- 4.10.1 Abbott Laboratories Company Information
- 4.10.2 Abbott Laboratories Business Overview
- 4.10.3 Abbott Laboratories Epigallocatechin Gallate (EGCG) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Abbott Laboratories Epigallocatechin Gallate (EGCG) Supplements Product Portfolio
- 4.10.5 Abbott Laboratories Recent Developments
5 Global Epigallocatechin Gallate (EGCG) Supplements Market Scenario by Region
- 5.1 Global Epigallocatechin Gallate (EGCG) Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Epigallocatechin Gallate (EGCG) Supplements Sales by Region: 2021-2032
- 5.2.1 Global Epigallocatechin Gallate (EGCG) Supplements Sales by Region: 2021-2026
- 5.2.2 Global Epigallocatechin Gallate (EGCG) Supplements Sales by Region: 2027-2032
- 5.3 Global Epigallocatechin Gallate (EGCG) Supplements Revenue by Region: 2021-2032
- 5.3.1 Global Epigallocatechin Gallate (EGCG) Supplements Revenue by Region: 2021-2026
- 5.3.2 Global Epigallocatechin Gallate (EGCG) Supplements Revenue by Region: 2027-2032
- 5.4 North America Epigallocatechin Gallate (EGCG) Supplements Market Facts & Figures by Country
- 5.4.1 North America Epigallocatechin Gallate (EGCG) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Epigallocatechin Gallate (EGCG) Supplements Sales by Country (2021-2032)
- 5.4.3 North America Epigallocatechin Gallate (EGCG) Supplements Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Epigallocatechin Gallate (EGCG) Supplements Market Facts & Figures by Country
- 5.5.1 Europe Epigallocatechin Gallate (EGCG) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Epigallocatechin Gallate (EGCG) Supplements Sales by Country (2021-2032)
- 5.5.3 Europe Epigallocatechin Gallate (EGCG) Supplements Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Epigallocatechin Gallate (EGCG) Supplements Market Facts & Figures by Country
- 5.6.1 Asia Pacific Epigallocatechin Gallate (EGCG) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Epigallocatechin Gallate (EGCG) Supplements Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Epigallocatechin Gallate (EGCG) Supplements Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Epigallocatechin Gallate (EGCG) Supplements Market Facts & Figures by Country
- 5.7.1 South America Epigallocatechin Gallate (EGCG) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Epigallocatechin Gallate (EGCG) Supplements Sales by Country (2021-2032)
- 5.7.3 South America Epigallocatechin Gallate (EGCG) Supplements Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Epigallocatechin Gallate (EGCG) Supplements Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Epigallocatechin Gallate (EGCG) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Epigallocatechin Gallate (EGCG) Supplements Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Epigallocatechin Gallate (EGCG) Supplements Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Epigallocatechin Gallate (EGCG) Supplements Sales by Type (2021-2032)
- 6.1.1 Global Epigallocatechin Gallate (EGCG) Supplements Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Epigallocatechin Gallate (EGCG) Supplements Sales Market Share by Type (2021-2032)
- 6.2 Global Epigallocatechin Gallate (EGCG) Supplements Revenue by Type (2021-2032)
- 6.2.1 Global Epigallocatechin Gallate (EGCG) Supplements Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Epigallocatechin Gallate (EGCG) Supplements Revenue Market Share by Type (2021-2032)
- 6.3 Global Epigallocatechin Gallate (EGCG) Supplements Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Epigallocatechin Gallate (EGCG) Supplements Sales by Application (2021-2032)
- 7.1.1 Global Epigallocatechin Gallate (EGCG) Supplements Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Epigallocatechin Gallate (EGCG) Supplements Sales Market Share by Application (2021-2032)
- 7.2 Global Epigallocatechin Gallate (EGCG) Supplements Revenue by Application (2021-2032)
- 7.2.1 Global Epigallocatechin Gallate (EGCG) Supplements Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Epigallocatechin Gallate (EGCG) Supplements Revenue Market Share by Application (2021-2032)
- 7.3 Global Epigallocatechin Gallate (EGCG) Supplements Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Epigallocatechin Gallate (EGCG) Supplements Value Chain Analysis
- 8.1.1 Epigallocatechin Gallate (EGCG) Supplements Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Epigallocatechin Gallate (EGCG) Supplements Production Mode & Process
- 8.2 Epigallocatechin Gallate (EGCG) Supplements Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Epigallocatechin Gallate (EGCG) Supplements Distributors
- 8.2.3 Epigallocatechin Gallate (EGCG) Supplements Customers
9 Global Epigallocatechin Gallate (EGCG) Supplements Analyzing Market Dynamics
- 9.1 Epigallocatechin Gallate (EGCG) Supplements Industry Trends
- 9.2 Epigallocatechin Gallate (EGCG) Supplements Industry Drivers
- 9.3 Epigallocatechin Gallate (EGCG) Supplements Industry Opportunities and Challenges
- 9.4 Epigallocatechin Gallate (EGCG) Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst